"Designing Growth Strategies is in our DNA"
The global colorectal cancer screening market size was valued at USD 14.32 billion in 2021. The market is projected to grow from USD 17.02 billion in 2022 to USD 22.88 billion by 2029, exhibiting a CAGR of 4.3% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with colorectal cancer screening experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. Based on our analysis, the market exhibited a decline of -59.6% in 2020 as compared to 2019.
Colorectal Cancer (CRC) occurs when the cancerous cells begin to grow and spread in the colon or rectum part of the digestive tract. It is also called bowel cancer. Early colorectal cancer cases begin with the development of non-cancerous polyps and can have no symptoms but can be detected through screening tests. CRC screening is the detection of the disease for people who are asymptomatic but at high risk of getting the disease and are of age 45 and above. Symptoms of CRC depend upon the size and site of cancer. Major disease symptoms include changes in bowel habits, stool consistency, blood in the stool, and abdominal discomfort. The increasing incidence of CRC has increased the need for screening for early diagnosis and treatment of the disease.
The global colorectal cancer screening market growth is attributed to its increasing prevalence of disease and rising government programs in order to control its side effects. Furthermore, the increasing focus of the market players on the launch of new and advanced products is one of the major factors driving the market growth.
COVID-19 Negatively Affected the Market due to Low Volume of Colorectal Cancer Screening
The impact of COVID-19 resulted in the decline of the CRC screening market growth during the pandemic. This was due to the lockdown restrictions and halt in CRC screening during the pandemic. Screening through colonoscopies was stopped entirely in 2020 in many countries in order to minimize person-to-person contact and to conserve hospital and medical resources for people exposed to COVID-19. Based on revenue, the global market witnessed a decline in its growth by -59.6% in 2020 compared to the prior year. The rate of people being screened through government programs also experienced a decline during the pandemic.
Moreover, the market players also experienced a decline in the sales of their products due to low demand during the pandemic. This resulted in a decrease in the revenues generated from the company’s CRC product portfolio.
However, there was a significant rebound in the global market in 2021, as CRC screening increased significantly, especially in high-burden countries. As the lockdown restrictions were relaxed, CRC screening increased and is expected to grow considerably as before the pandemic.
Request a Free sample to learn more about this report.
Emergence of New Technologies to Boost the Market Growth
The market players have increased their focus on the development and commercialization of technologically advanced products for efficient screening due to the increasing incidence of colorectal cancer globally and increasing awareness regarding the early testing and treatment of the disease.
The market players in recent years have developed products for the detection of CRC, which identifies cells released by colorectal polyps and tumors into the bloodstream for cancer screening.
The approval and commercialization of these screening tests are expected to encourage other market players to launch more tests to increase the volume of tests for colorectal cancer during the forecast period.
Such new technologies for the detection of CRC are increasing the adoption of tests, thereby fueling the overall global market growth.
Government Initiatives and Policies Associated with Colorectal Cancer Screening Tests to Drive the Market
Government across various countries has increased the policies for CRC screening in order to reduce the disease globally. In order to control the increasing burden of CRC, government across many countries has taken certain initiatives such as regular screening programs for individuals who are at risk of getting affected by the disease. Many countries have increased their emphasis on the development of policies to increase the screening rates for colorectal cancer.
These programs help in the detection of CRC at minimal cost and are one of the prominent factors increasing the number of screening procedures being conducted globally, especially in developed countries such as the United States, South Korea, and the U.K.
The increasing aging population coupled with government initiatives are expected to propel the adoption of various tests, thereby fueling the overall market growth.
Increasing Incidence of Colorectal Cancer to Boost the Market Growth
One of the major drivers that is positively impacting the growth of the market is the significant increase in the incidence of CRC globally. Colorectal cancer is one of the leading cause of death in countries across the globe
The incidence of CRC is higher in developed countries, and it is increasing in middle- and low-income countries due to unhealthy lifestyle choices and a surge in the aging population in these countries.
Such increasing incidence of CRC and its increasing mortality rate has increased the demand for the detection of CRC and is expected to propel the global colorectal cancer screening market growth in the coming years.
Adverse Effects of Colonoscopies to Limit Colonoscopy Tests in the Future
Despite a serious and increased need for advanced and efficient screening procedures, certain limitations associated with the screening devices can limit their adoption.
For instance, colonoscopy is a highly accurate test and has the highest positivity rate. However, there are several side effects associated with the colonoscopy procedure, such as infection and bleeding, which can be caused to the patient after the colonoscopy procedure is done.
Furthermore, there are several post-colonoscopy complications, such as severe pain or belly cramps, a hard belly, trouble passing gas or pooping, fever, dizziness, vomiting, frequent or severely bloody bowel movements, rectal bleeding that won't stop, or excess bleeding, which is anticipated to reduce the number of colonoscopy procedures during the forecast period.
Such limitations and adverse effects associated with CRC screening procedures are expected to hamper the market growth during the forecast timeframe.
To know how our report can help streamline your business, Speak to Analyst
High Positivity Rate Associated with Screening through Colonoscopes to Boost the Segment’s Growth
Based on type, the global market is segregated into stool-based, colonoscopy, and others. The colonoscopy segment generated the highest revenue in 2021 and is expected to grow at a moderate CAGR during the forecast timeframe. The segment’s dominant share is attributed to the high accuracy of the procedure and the increasing incidence of colorectal cancer.
Furthermore, stool-based tests are expected to grow at the highest rate during the forecast timeframe. The segment’s growth is due to the rising government programs for CRC screening and time-efficient results obtained from stool-based tests. The stool-based segment is further sub-segmented into fecal occult blood tests (gFOBT), fecal immunochemical tests (FIT/iFOBT), and stool-DNA tests. The FIT screening tests are expected to grow at a significant CAGR during the forecast period due to their simple use and high positivity rate as compared to other stool-based tests.
Strong Presence of Hospitals & Clinics to Boost Segment’s Growth
Based on end-user, the market is categorized into hospitals & clinics, clinical laboratories, diagnostic imaging centers, and others.
The hospitals & clinics segment accounted for a significant share of the market in 2021. Factors such as the presence of a substantial number of hospitals and the increasing number of CRC screening procedures conducted in hospitals are responsible for the segment’s growth.
The diagnostics imaging centers are estimated to grow at a significant CAGR during the forecast period. The increasing trend of CRC screening through colonoscopies and the increasing number of diagnostics centers conducting colonoscopy procedures across the world are some of the key factors contributing to segmental growth.
North America Colorectal Cancer Screening Market Size, 2021 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
The North American colorectal cancer screening market generated a revenue of USD 9.27 billion in 2021. The highly aware and economically stable population is a key factor for the large share of the market in North America. Moreover, the adoption of technologically advanced and high-cost tests such as Cologuard, colonoscopies, and other stool-based tests in the region is also expected to propel the market growth during the forecast period.
The market in Europe is expected to grow at a significant CAGR during the forecast period. Increasing demand for screening procedures such as stool-based testing in European countries, the presence of government programs, and rising awareness about the disease in key European countries are some of the major factors expected to boost market growth in Europe.
The market across Asia Pacific region is expected to expand at a substantial CAGR in the projected years. The enhancement and improvement of healthcare facilities in Asian countries, increasing CRC incidence the countries across the region, and the increasing consciousness of the individuals in terms of better treatment outcomes are driving the regional market growth.
The market in Middle East & Africa, and Latin America are also expected to expand at a significant CAGR during the forecast period. The increasing burden of colorectal cancer, rising government initiatives to create awareness about the disease along with easy availability of screening tests such as FIT and FOBT are responsible for the growth of the market for colorectal cancer screening across these regions.
Companies with Strong Focus on Expansion of Colorectal Cancer Screening Portfolio to Hold Key Market Share
Olympus Corporation, Exact Sciences Corporation, and Quest Diagnostics are the prominent players in the market and captured a considerable global colorectal cancer screening market share in 2021.
Olympus Corporation and Exact Sciences Corporation accounted for major shares of the market in 2021. Olympus Corporation dominated the market in 2021, accounting for a significant market share. This was due to the company’s product portfolio for colonoscopy, which consists of efficient and technologically advanced colonoscopes.
Similarly, Exact Sciences Corporation held a considerable share of the market in 2021. This was due to the company’s product Cologuard with a strong sales and distribution network in the U.S.
Other significant players, including FUJIFILM Holdings Corporation, Laboratory Corporation of America Holdings, and Clinical Genomics Technologies Pty Ltd, are emphasizing research and development activities for the launch of new and technologically advanced products in order to strengthen their market position.
An Infographic Representation of Colorectal Cancer Screening Market
To get information on various segments, share your queries with us
The market report provides a detailed competitive landscape. It includes the incidence of CRC and key industry developments such as partnerships, mergers, & acquisitions. Additionally, it focuses on key points such as new product launches in the market. Furthermore, the report covers regional analysis of different segments, company profiles of key market players, s, and the impact of COVID-19 on the market. The report consists of quantitative and qualitative insights that contribute to the market's growth.
Value (USD Billion)
Type; End-user; and Region
Fortune Business Insights says that the global market stood at USD 14.32 billion in 2021 and is projected to reach USD 22.88 billion by 2029.
The market is expected to exhibit a CAGR of 4.3% during the forecast period (2022-2029).
The colonoscopy segment is set to lead the market by type.
The key factors driving the market are favorable government policies, high incidence of colorectal cancer, and increasing initiatives by market players for the development of technologically advanced products.
Olympus Corporation, Exact Sciences Corporation, and Quest Diagnostics are the top players in the market.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry